Authors:
Lohr, M
Muller, P
Zauner, I
Schmidt, C
Trautmann, B
Thevenod, F
Capella, G
Farre, A
Liebe, S
Jesnowski, R
Citation: M. Lohr et al., Immortalized bovine pancreatic duct cells become tumorigenic after transfection with mutant k-ras, VIRCHOWS AR, 438(6), 2001, pp. 581-590
Authors:
Lohr, M
Schmidt, C
Ringel, J
Kluth, M
Muller, P
Nizze, H
Jesnowski, R
Citation: M. Lohr et al., Transforming growth factor-beta 1 induces desmoplasia in an experimental model of human pancreatic carcinoma, CANCER RES, 61(2), 2001, pp. 550-555
Authors:
Lohr, M
Bago, ZT
Bergmeister, H
Ceijna, M
Freund, R
Gelbmann, W
Gunzburg, WH
Jesnowski, R
Hain, J
Hauenstein, K
Henninger, W
Hoffmeyer, A
Karle, P
Kroger, JC
Kundt, G
Liebe, S
Losert, U
Muller, P
Probst, A
Puschel, K
Renner, M
Renz, R
Saller, R
Salmons, B
Schuh, M
Schwendenwein, I
von Rombs, K
Wagner, T
Walter, I
Citation: M. Lohr et al., Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study, J MOL MED-J, 77(4), 1999, pp. 393-398